Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections

Liting Cheng,Miao-Miao Niu,Tong Yan,Zhongyi Ma,Kexin Huang,Ling Yang,Xin Zhong,Chong Li
DOI: https://doi.org/10.1016/j.apsb.2021.04.020
IF: 14.903
2021-10-01
Acta Pharmaceutica Sinica B
Abstract:<p>As a typical human pathogenic fungus, <em>Cryptococcus neoformans</em> is a life-threatening invasive fungal pathogen with a worldwide distribution causing ∼700,000 deaths annually. Cryptococcosis is not just an infection with multi-organ involvement, intracellular survival and extracellular multiplication of the fungus also play important roles in the pathogenesis of <em>C. neoformans</em> infections. Because adequate accumulation of drugs at target organs and cells is still difficult to achieve, an effective delivery strategy is desperately required to treat these infections. Here, we report a bioresponsive micro-to-nano (MTN) system that effectively clears the <em>C. neoformans in vivo</em>. This strategy is based on our in-depth study of the overexpression of matrix metalloproteinase 3 (MMP-3) in infectious microenvironments (IMEs) and secreted protein acidic and rich in cysteine (SPARC) in several associated target cells. In this MTN system, bovine serum albumin (BSA, a natural ligand of SPARC) was used for the preparation of nanoparticles (NPs), and then microspheres were constructed by conjugation with a special linker, which mainly consisted of a BSA-binding peptide and an MMP-3-responsive peptide. This MTN system was mechanically captured by the smallest capillaries of the lungs after intravenous injection, and then hydrolyzed into BSA NPs by MMP-3 in the IMEs. The NPs further targeted the lung tissue, brain and infected macrophages based on the overexpression of SPARC, reaching multiple targets and achieving efficient treatment. We have developed a size-tunable strategy where microspheres "shrink" to NPs in IMEs, which effectively combines active and passive targeting and may be especially powerful in the fight against complex fungal infections.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop an effective drug - delivery system for complex fungal infections, especially those caused by *Cryptococcus neoformans*. Cryptococcus is a human - pathogenic fungus distributed globally, causing about 700,000 deaths every year. This fungus not only infects multiple organs but also can survive and reproduce both inside and outside cells, increasing the difficulty of treatment. Since existing antifungal drugs are difficult to reach sufficient concentrations in target organs and cells, an effective delivery strategy is required to improve the treatment effect. For this purpose, the researchers designed an albumin - based bio - responsive micro - nano system (MTN system), which can effectively clear Cryptococcus in vivo. The core of this strategy lies in taking advantage of the over - expression of matrix metalloproteinase 3 (MMP - 3) in the infected micro - environment (IMEs) and the over - expression of secreted protein acidic and rich in cysteine (SPARC) in certain target cells. By using bovine serum albumin (BSA) as the preparation material for nanoparticles (NPs) and combining with specific linkers (consisting of BSA - binding peptides and MMP - 3 - responsive peptides), a system that can respond to MMP - 3 and transform from microspheres to nanoparticles was constructed. This transformation enables the nanoparticles to further target lung tissues, the brain and infected macrophages, achieving multi - target and highly - efficient treatment. In conclusion, this study aims to overcome the physiological and pathological obstacles in the treatment of complex fungal infections and improve the drug - targeting efficiency and treatment effect by developing a new type of bio - responsive drug - delivery system.